LMAT Stock Recent News

LMAT LATEST HEADLINES

LMAT Stock News Image - fool.com

LeMaitre (LMAT) Q2 Revenue Jumps 15%

fool.com 2025 Aug 06
LMAT Stock News Image - seekingalpha.com

LeMaitre Vascular, Inc. (NASDAQ:LMAT ) Q2 2025 Earnings Conference Call August 5, 2025 5:00 PM ET Company Participants David B. Roberts - President & Director Dorian LeBlanc - Chief Financial Officer George W.

seekingalpha.com 2025 Aug 06
LMAT Stock News Image - zacks.com

LeMaitre Vascular (LMAT) came out with quarterly earnings of $0.6 per share, beating the Zacks Consensus Estimate of $0.57 per share. This compares to earnings of $0.52 per share a year ago.

zacks.com 2025 Aug 05
LMAT Stock News Image - globenewswire.com

BURLINGTON, Mass., Aug. 05, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants, and services, today reported Q2 2025 results, announced a quarterly dividend of $0.20/share, and provided guidance.

globenewswire.com 2025 Aug 05
LMAT Stock News Image - zacks.com

Investors with an interest in Medical - Products stocks have likely encountered both Phibro Animal Health (PAHC) and LeMaitre Vascular (LMAT). But which of these two stocks presents investors with the better value opportunity right now?

zacks.com 2025 Aug 04
LMAT Stock News Image - globenewswire.com

BURLINGTON, Mass., July 08, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its second quarter 2025 financial results on Tuesday, August 5, 2025, after the market close. The company has scheduled a conference call for 5:00 PM EDT the same day to discuss the results, business highlights, and company outlook.

globenewswire.com 2025 Jul 08
LMAT Stock News Image - seekingalpha.com

We avoid very high-yielding stocks, as the best way to grow richer over time is to own a diversified basket of dividend growth stocks. Today, we're highlighting a leading alternative asset manager, a niche medical devices company, and Michigan's largest regulated utility. Relative to our fair value estimates, the trio of fast-growing businesses are trading at 4% to 7% discounts.

seekingalpha.com 2025 Jun 29
LMAT Stock News Image - seekingalpha.com

LeMaitre's revenue and earnings continue to grow, though profit growth has moderated. The European launch of Artegraft and pending approval of XenoSure in China are key near-term catalysts. The portfolio's increasing share of biologic products combined with operational improvements are supporting high margins.

seekingalpha.com 2025 Jun 17
LMAT Stock News Image - globenewswire.com

BURLINGTON, Mass., May 05, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will present at the Bank of America Securities 2025 Healthcare Conference on Tuesday, May 13, 2024, at 5:00 PM PDT at the Encore at the Wynn Hotel in Las Vegas, NV.

globenewswire.com 2025 May 05
LMAT Stock News Image - seekingalpha.com

LeMaitre Vascular, Inc. (LMAT) Q1 2025 Earnings Call Transcript

seekingalpha.com 2025 May 01
10 of 50